Table 2. Muscle development and lipid metabolism-related Gene Ontology (GO) analysis results.
| Term | ID | Corrected p | Genes |
| Cellular lipid metabolic process | GO:0044255 | 3.26 × 10−3 | ST3GAL1, CETP, PDK4, CYR61, AGTR1, UCP3, HPGD |
| Lipid metabolic process | GO:0006629 | 1.18 × 10−2 | ST3GAL1, CETP, PDK4, CYR61, AGTR1, UCP3, HPGD |
| Regulation of lipid metabolic process | GO:0019216 | 4.29 × 10−2 | AGTR1, CYR61, PDK4 |
| Sphingolipid biosynthetic process | GO:0030148 | 4.61 × 10−2 | ST3GAL1, CYR61 |
| Fatty acid metabolic process | GO:0006631 | 4.65 × 10−2 | UCP3, PDK4, HPGD |
| Regulation of lipase activity | GO:0060191 | 4.73 × 10−2 | AGTR1, CYR61 |
| Skeletal muscle cell differentiation | GO:0035914 | 1.27 × 10−3 | ASB2, HLF, MAFF, FOS |
| Muscle structure development | GO:0061061 | 2.82 × 10−3 | ASB2, HOPX, FOS, FHL2, HLF, MAFF |
| Striated muscle tissue development | GO:0014706 | 3.73 × 10−3 | FHL2, HLF, ASB2, MAFF, FOS |
| Muscle tissue development | GO:0060537 | 4.22 × 10−3 | FHL2, HLF, ASB2, MAFF, FOS |
| Skeletal muscle tissue development | GO:0007519 | 4.50 × 10−3 | ASB2, HLF, MAFF, FOS |
| Skeletal muscle organ development | GO:0060538 | 5.28 × 10−3 | ASB2, HLF, MAFF, FOS |
| Muscle organ development | GO:0007517 | 1.59 × 10−2 | ASB2, HLF, MAFF, FOS |
Note: AGTR1, angiotensin II receptor type 1; ASB2, ankyrin repeat and SOCS box containing 2; CETP, cholesteryl ester transfer protein; CYR61, cysteine-rich angiogenic inducer 61; FHL2, four and a half LIM domains 2; FOS, Fos proto-oncogene, AP-1 transcription factor subunit; HLF, HLF, PAR bZIP transcription factor; HOPX, HOP homeobox; HPGD, hydroxyprostaglandin dehydrogenase 15-(NAD); MAFF, MAF bZIP transcription factor F; PDK4, pyruvate dehydrogenase kinase 4; ST3GAL1, ST3 beta-galactoside alpha-2,3-sialyltransferase 1; UCP3, uncoupling protein 3.